Acadia Pharmaceuticals

Acadia Pharmaceuticals is a U.S.-based company that has been working for over 30 years to develop innovative solutions for neurological disorders, including Parkinson's disease psychosis, Rett syndrome, and other central nervous system conditions. The company has pioneered the first and only approved therapies for hallucinations and delusions associated with these conditions, and its clinical-stage developments focus on addressing Prader-Willi syndrome, Alzheimer's disease psychosis, and neuropsychiatric symptoms.